<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta(2)-GPI=<z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> H) is an important autoantigen in patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It also plays a role in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism, such as anti-atherogenic property, <z:chebi fb="0" ids="17855">triglyceride</z:chebi> removal, and enhancement of <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase </plain></SENT>
<SENT sid="2" pm="."><plain>Serum beta(2)-GPI concentration of 812 apparently healthy Japanese individuals was measured by sandwich EIA </plain></SENT>
<SENT sid="3" pm="."><plain>Two families with complete beta(2)-GPI deficiency were identified </plain></SENT>
<SENT sid="4" pm="."><plain>In one family, <z:hpo ids='HP_0000001'>all</z:hpo> affected had increased serum <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> levels or smaller particle sizes of <z:chebi fb="15" ids="39026">LDL</z:chebi>, while the other had no apparent abnormality in <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism </plain></SENT>
<SENT sid="5" pm="."><plain>Individuals investigated had no history of <z:mp ids='MP_0005048'>thrombosis</z:mp> or overt abnormalities in hemostatic tests </plain></SENT>
<SENT sid="6" pm="."><plain>A <z:chebi fb="2" ids="17821">thymine</z:chebi> corresponding to position 379 of the beta(2)-GPI cDNA was deleted in every beta(2)-GPI deficient individual </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of this heterozygous deficiency determined by RFLP was 6 </plain></SENT>
<SENT sid="8" pm="."><plain>3% in Japanese and none in Caucasians </plain></SENT>
<SENT sid="9" pm="."><plain>Heterozygotes had significantly lower concentrations of serum beta(2)-GPI than did those without the mutation, yet no significantly different <z:chebi fb="23" ids="18059">lipid</z:chebi> profiles, such as total cholesterol, <z:chebi fb="0" ids="17855">triglyceride</z:chebi>, <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, apoA-I, apoB and Lp(a), were observed </plain></SENT>
<SENT sid="10" pm="."><plain>A low concentration of beta(2)-GPI seemed not to be associated with apparent abnormality in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism </plain></SENT>
</text></document>